Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 4,131 | 0 | 0 | 0 | 48 |
| Cost of Goods | 3,935 | N/A | N/A | N/A | 6 |
| Gross Profit | 196 | N/A | N/A | N/A | 41 |
| Operating Expenses | 48,089 | 27,191 | 10,751 | 9,421 | 7,200 |
| Operating Income | -46,958 | -27,191 | -10,751 | -9,421 | -7,152 |
| Interest Expense | 0 | 0 | 0 | 26 | 82 |
| Other Income | 1,596 | -280 | -19 | -7 | 28 |
| Pre-tax Income | -45,362 | -27,471 | -10,770 | -9,454 | -7,206 |
| Net Income Continuous | -45,362 | -27,471 | -10,770 | -9,454 | -7,206 |
| Minority Interests | 670 | N/A | N/A | N/A | N/A |
| Net Income | $-46,032 | $-27,471 | $-10,770 | $-9,454 | $-7,206 |
| EPS Basic Total Ops | -4.80 | -3.20 | -1.80 | -1.70 | -2.20 |
| EPS Basic Continuous Ops | -4.73 | -3.24 | -1.75 | -1.69 | -2.22 |
| EPS Diluted Total Ops | -4.80 | -3.20 | -1.80 | -1.70 | -2.20 |
| EPS Diluted Continuous Ops | -4.73 | -3.24 | -1.75 | -1.69 | -2.22 |
| EPS Diluted Before Non-Recurring Items | -4.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-44,805 | $-25,520 | $-10,634 | $-9,354 | $-7,084 |